Johnson & Johnson (JNJ) Current Taxes (2009 - 2026)
Johnson & Johnson (JNJ) posted Current Taxes of $1.1 billion for Q1 2026, down 21.69% sequentially from $1.4 billion in Q4 2025, and down 74.22% YoY from $4.2 billion in Q1 2025.
Johnson & Johnson (JNJ) Current Taxes (2009 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 18 years of Current Taxes data on file, last reported at $1.1 billion in Q1 2026.
- Quarterly Current Taxes fell 74.22% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 74.22% YoY) and the FY2025 annual result came in at $1.4 billion, down 63.2% from the prior year.
- Current Taxes declined to $1.1 billion in Q1 2026 per JNJ's latest filing, from $1.4 billion in the prior quarter.
- The five-year high for Current Taxes was $4.8 billion in Q3 2024, with the low at $1.1 billion in Q1 2026.
- Average Current Taxes over 5 years is $2.7 billion, with a median of $2.5 billion recorded in 2023.
- Year-over-year, Current Taxes soared 149.77% in 2023 and tumbled 74.22% in 2026.
- Johnson & Johnson's Current Taxes stood at $2.0 billion in 2022, then soared by 50.7% to $3.0 billion in 2023, then rose by 26.03% to $3.8 billion in 2024, then slumped by 63.2% to $1.4 billion in 2025, then declined by 21.69% to $1.1 billion in 2026.
- Business Quant data shows JNJ's Current Taxes at $1.1 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 1.09 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -1.30 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 3.95 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.13 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 93.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 1.09 Bn |
| Dec 28, 2025 | 1.39 Bn |
| Sep 28, 2025 | 1.93 Bn |
| Jun 29, 2025 | 1.67 Bn |
| Mar 30, 2025 | 4.22 Bn |
| Dec 29, 2024 | 3.77 Bn |
| Sep 29, 2024 | 4.83 Bn |
| Jun 30, 2024 | 4.31 Bn |
| Mar 31, 2024 | 3.32 Bn |
| Dec 31, 2023 | 2.99 Bn |
| Oct 1, 2023 | 2.90 Bn |
| Jul 2, 2023 | 2.69 Bn |
| Apr 2, 2023 | 4.27 Bn |
| Jan 1, 2023 | 2.22 Bn |
| Oct 2, 2022 | 1.99 Bn |
| Jul 3, 2022 | 1.98 Bn |
| Apr 3, 2022 | 1.71 Bn |
| Jan 2, 2022 | 1.11 Bn |
| Oct 3, 2021 | 2.16 Bn |
| Jul 4, 2021 | 1.20 Bn |